Skip to main content
Top
Published in: Reactions Weekly 1/2024

01-03-2024 | Fingolimod | Case report

Fingolimod/natalizumab

Drug intolerance and cryptococcal meningoencephalitis

Published in: Reactions Weekly | Issue 1/2024

Login to get access

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literature
go back to reference Nasir M, et al. Cryptococcal meningoencephalitis in multiple sclerosis treated with fingolimod. Practical Neurology 23: 512-515, No. 6, Jan 2023. Available from: URL: https://dx.doi.org/10.1136/pn-2023-003691 Nasir M, et al. Cryptococcal meningoencephalitis in multiple sclerosis treated with fingolimod. Practical Neurology 23: 512-515, No. 6, Jan 2023. Available from: URL: https://​dx.​doi.​org/​10.​1136/​pn-2023-003691
Metadata
Title
Fingolimod/natalizumab
Drug intolerance and cryptococcal meningoencephalitis
Publication date
01-03-2024
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2024
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-024-54858-6

Other articles of this Issue 1/2024

Reactions Weekly 1/2024 Go to the issue

Case report

Morphine